Icelandic program seeks to eliminate HCV

March 7, 2018, Wiley
Electron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University.

A new Journal of Internal Medicine study describes an innovative program to eliminate hepatitis C virus (HCV) as a public health threat in Iceland.

In the TraP Hep C program, which started in January 2016, an emphasis is placed on finding early cases and treating patients at high risk for transmitting HCV: people who inject drugs. All patients with national health insurance are offered treatment regardless of fibrosis stage and .

The program includes a multidisciplinary public health model of care and cooperation between government, health services, the penitentiary system, and community organizations. The results of the Icelandic project will provide important data and inform others globally trying to achieve the World Health Organization's goal of HCV elimination by 2030.

"So far this project has been extremely well received by patients, and we are aiming to complete the active treatment phase, encompassing all known cases in the country, by the end of 2018," said senior author Dr. Magnus Gottfredsson, of the University of Iceland.

Explore further: More than one third of U.S. HIV patients fail to receive vaccination for hepatitis B

More information: S. Olafsson et al, Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents, Journal of Internal Medicine (2018). DOI: 10.1111/joim.12740

Related Stories

More than one third of U.S. HIV patients fail to receive vaccination for hepatitis B

December 25, 2017
Despite their high risk for infection, more than one third of U.S. HIV patients fail to get vaccinated for hepatitis B. The findings are published in Annals of Internal Medicine.

Only nine countries on track to eliminate hepatitis C

November 1, 2017
New data on hepatitis C released by the Polaris Observatory, and presented today at the World Hepatitis Summit (WHS) in Sao Paulo, Brazil shows that nine countries—Australia, Brazil, Egypt, Georgia, Germany, Iceland, Japan, ...

Countries risk 'running out' of hepatitis C patients to treat, says World Hepatitis Alliance

November 1, 2017
The latest data on the global hepatitis C epidemic, released today at the World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) reveal that most countries (especially high-income countries) are running out of patients ...

World Hepatitis Day sets the stage for the elimination of viral hepatitis

July 28, 2017
Today, World Hepatitis Day, marks the first time that the global health community has come together to officially begin moving towards the elimination of viral hepatitis by 2030.

People who use drugs require prioritization, not exclusion, in HCV elimination

September 6, 2017
An international conference bringing together hepatitis C experts from around the world is today calling for strategies to prioritise people who use drugs, saying hepatitis C elimination is impossible without them.

Australia currently on track to eliminate hepatitis C by 2030, but challenges remain for hepatitis B

November 1, 2017
New data released at this year's World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) shows that Australia is currently on track to eliminate hepatitis C thanks to its huge efforts to enable population-wide access to ...

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.